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Abstract To examine the association between overweight/
obesity and healthcare utilization in middle-aged and aged
Europeans. This is a baseline cross-sectional analysis of
self-reported data from ten countries participating in the
Survey of Health, Ageing and Retirement in Europe
(SHARE), which reached an overall response rate of 62%.
Included in the study were 16,695 non-institutionalized
individuals aged 50–79 years with body mass indexes
(BMI) ≥18.5 kg/m2. We used height and weight to compute
BMI and categorized it into normal weight (BMI 18.5–
24.9 kg/m2), overweight (BMI 25.0–29.9 kg/m2) and
obesity (BMI≥30 kg/m2). Dichotomous measures of health-
care utilization during the previous 12 months included any
use of ambulatory care, high use of a general practitioner,
visits to specialists, high use of medication, hospitalization,
high number of times hospitalized and nights spent in the
hospital, surgery, home healthcare and domestic help.
Logistic regressions adjusted for age, socio-economic
status, smoking, physical activity, alcohol consumption,
country of residence, and chronic conditions. All analyses
were stratified by gender. Among men and women, being
overweight or obese was associated with a significantly
increased risk of using ambulatory care and visiting general
practitioners, as well as taking ≥2 medication categories.
Those relationships were only partially explained by
chronic conditions. Obese women were at increased risk
and overweight men at decreased risk of hospitalization.
For men, exploring other hospitalization dimensions did
not reveal significant associations, however. Men and
women, whether overweight or obese, did not report higher
use of specialists, surgery, home healthcare or domestic
help. For all outcomes, similar trends were found at the
country level. Population-attributable fractions were high-
est for medication use, both for men (23%) and women
(19%). Despite the rising prevalence of obesity and aging
of the population, findings from SHARE show that
overweight and obesity place a moderate burden on
European healthcare systems, mostly by increasing ambu-
latory care and medication use.
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Introduction
In Europe, as in most other industrialized countries,
population aging (Lloyd-Sherlock 2000) and the prevalence
of overweight and obesity continue to rise over time (Flegal
et al. 2002; Mokdad et al. 2001). The higher frequency of
chronic diseases (Haslam and James 2005; Field et al.
2001), physical disability (Larrieu et al. 2004; Lean et al.
1999) and poorer health-related quality of life (Groessl et
al. 2004; Arterburn et al. 2004; Fontaine and Barofsky
2001) of overweight/obese and elderly individuals drives
healthcare utilization. This is of particular concern because
it has been estimated that the rising prevalence of obesity is
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likely to reduce, or even reverse, the recent improvements
in disability among the elderly (Sturm et al. 2004).
The issue of the burden that the overweight and obese
place on the healthcare system in terms of healthcare
utilization is of recent interest and has been increasingly
commented on in the literature in the past few years
(Bertakis and Azari 2005; Leon-Munoz et al. 2005; von
Lengerke et al. 2005; Andreyeva et al. 2004; Meisinger et
al. 2004; Raebel et al. 2004; Luchsinger et al. 2003;
Guallar-Castillon et al. 2002; Ostbye et al. 2002; Reidpath
et al. 2002; Quesenberry et al. 1999; Trakas et al. 1999;
Fontaine et al. 1998). Despite the fact that the countries,
populations considered, age range, utilization window time
and confounding adjustment somewhat differed across
studies, it has been shown that obesity is generally
associated with higher ambulatory care visits and drug
consumption, but not consistently with higher hospitaliza-
tion rates. The majority of studies used North American
data (Bertakis and Azari 2005; Andreyeva et al. 2004;
Luchsinger et al. 2003; Reidpath et al. 2002; Quesenberry
et al. 1999; Trakas et al. 1999; Fontaine et al. 1998), and an
overall European picture is lacking. Exploring this issue
across Europe would be of interest since healthcare
accessibility is theoretically less problematic in Europe,
compared to the United States. In Europe, actually, more
than 90% of European residents are covered by public or
private health insurance plans (Colombo and Tapay 2004).
In this study we aimed to assess the impact on health
systems of overweight and obesity in European men and
women. Therefore, we examined the association between body
mass index (BMI) and a range of healthcare utilization
measures, using standardized individual-level data allowing
for comprehensive adjustment. We hypothesized that being
either overweight or obese would be associated with a
generally increased use of health services in both genders,
irrespective of the country (and healthcare system) considered.
Methods
Setting, participants and data
This study involved the secondary analysis of data from the
Survey of Health, Ageing and Retirement in Europe
(SHARE) 2004, release 1 (Börsch-Supan et al. 2005). It
may contain errors that will be corrected in later releases,
but which would most probably not invalidate the current
findings. Baseline cross-sectional data collection of non-
institutionalized individuals aged 50 years and over was
organized in 2004 in each of the ten participating countries:
Austria, Denmark, France, Germany, Greece, Italy, Spain,
Sweden, Switzerland and the Netherlands. An overall
response rate of 61.8% was obtained (Börsch-Supan and
Jürges 2005), with response rates varying from 50.2 to
73.6%, except in Switzerland, which reached only 37.6%.
SHARE information was collected through standardized
face-to-face interviews. We pooled the responses from all
ten countries and restricted the sample to the 17,303
respondents aged 50 to 79 years old. Of those, we excluded
438 (2.5%) persons with missing or implausible informa-
tion regarding height, weight or body mass index, and 170
(1%) underweight individuals (BMI<18.5 kg/m2). The
working sample consisted of 16,695 subjects.
Measures
Height and weight were self-reported, and BMI was
calculated as the weight in kilograms divided by the square
of the height in meters (kg/m2). The participants were
divided into three BMI categories: normal weight (BMI
18.5–24.9 kg/m2), overweight (BMI 25.0–29.9 kg/m2) and
obesity (BMI≥30.0 kg/m2).
Healthcare utilization during the previous 12 months
included the reported number of ambulatory care visits, and
among respondents with at least one ambulatory care visit,
data were collected on the number of visits to general
practitioners and whether specialists were consulted (yes/
no); hospitalization (yes/no), and among respondents who
were hospitalized, data were collected on the number of
separate hospital stays and on the total number of nights the
respondent spent in the hospital; whether any surgery was
required either as an in- or out-patient (yes/no); the number
of medication categories taken at least once a week; the use
of home healthcare (yes/no) and of domestic help (yes/no).
The number of total and general practitioner ambulatory
care visits, of separate hospitalizations, of the total number
of nights spent in the hospital and medication categories
taken were dichotomized into high (>sample median) and
low (≤ sample median) use. For each of the latter
outcomes, the median was determined separately for men
and women.
Adjustment was considered for the following potential
confounders: age, country of residence, marital status,
socio-economic status as measured by years of education
and purchasing power parity-household income (Euros)
adjusted for the size of the household (ppp-household
income), smoking, physical activity, alcohol consumption,
supplementary insurance (any voluntary, supplementary or
private health insurance) and physician-diagnosed chronic
conditions related to obesity (heart disease including
myocardial infarction, high blood pressure, high cholester-
ol, diabetes and arthritis). The goal of the adjustment for
chronic conditions was to determine the extent to which
associations between BMI and utilization could be
explained by diseases known to be related to overweight
or obesity. All the collected variables were self-reported.
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Statistical analysis
First, healthcare utilization was compared across BMI
categories using chi-squared tests. Then, separate multiple
regressions were used to assess the association between
BMI and each utilization outcome variable, considering the
normal weight category as the reference. Because home
healthcare and domestic help questions were not asked of
Greek and Swiss participants, those two countries were
excluded from the analyses of these two outcomes. Three
separate logistic regression models, which included the
following variables, were built : model 1: age and country
of residence; model 2: as model 1 + socio-economic status,
smoking, physical activity and alcohol consumption; model
3: as model 2 + obesity-related chronic conditions. We also
tested whether supplementary insurance status changed the
point estimates by adjusting for it in model 2. The joint
Wald test was used to evaluate interactions between the
following categorical variables: BMI and countries, and
BMI and age categories (50–64 years/65–79 years). In the
working sample, none of the variables considered had ≥2%
missing data.
For the statistically significant associations between
overweight/obesity and healthcare utilization, we assessed
population-attributable fractions (PAF). This was done
using the equation PAF=p * (OR−1/OR) where OR is the
adjusted odds ratio for overweight or obesity, and p
represents the proportion of patients that were overweight
or obese (Rockhill et al. 1998). The PAF values for
overweight and obesity represent the proportion of cases
of healthcare utilization that we could expect to be
prevented if overweight and obesity were eliminated.
All analyses (except country-level analysis) were strat-
ified by gender and performed using Stata 8.0. P values<
0.05 were considered significant.
Results
According to SHARE, 50.7% of European men aged 50 to
79 years were overweight and 16.2% were obese, while
36.9% of European women of similar age were overweight
and 19.1% obese. The estimated prevalences of overweight
and obesity across countries and gender are described in
Table 1. They highlight that Austria, Greece and Spain had
the highest prevalence of obesity among both men and
women. Characteristics of the study population are pre-
sented by gender in Table 2.
Table 3 shows the unadjusted comparisons of health
services utilization during the previous 12 months, by BMI
category and gender. Except for visits to specialists and
surgery, utilization significantly increased with higher BMI
both for men and women. Hospitalization and home health
services were only significantly more prevalent among
overweight and obese women. The adjusted odds ratios are
presented in Table 4. Among men and women, overweight
and obesity were associated with a significantly increased
risk of having any ambulatory care visit, being a high user
of ambulatory care visits, being a high user of general
practitioner visits and being a high user of medication.
These associations between BMI and healthcare utilization
were not fully explained by obesity-related chronic con-
ditions, suggesting that only part of the use may be
attributable to these diseases.
For all the non-significant associations found using
model 3, subdividing obesity (BMI≥30 kg/m2) into obesity
class I (BMI 30.0–34.9 kg/m2) and obesity class II and III
(BMI≥35.0 kg/m2) showed similar results. When we
consider only fully adjusted odds ratios (model 3) that
were significant, the subdivision of BMI into more
categories revealed a slight, but not consistently significant
“dose-response” relationship for high use of general
Table 1 Estimated prevalence
of overweight (BMI 25.0–
29.9 kg/m2) and obesity
(BMI≥30.0 kg/m2) by gender
and country (n=16,695)
Men (n=7,854) Women (n=8,841)
Working sample size (n) Overweight Obese Overweight Obese
Austria 1,697 52.3% 18.6% 35.7% 21.1%
Denmark 1,384 46.1% 14.9% 33.0% 14.5%
France 1,449 48.4% 15.4% 30.3% 16.6%
Germany 2,096 51.6% 17.2% 38.5% 18.5%
Greece 1,725 55.5% 17.8% 41.3% 23.6%
Italy 1,804 51.6% 16.1% 39.2% 19.5%
The Netherlands 2,041 48.3% 14.9% 36.7% 18.1%
Spain 1,433 49.9% 21.0% 41.0% 26.9%
Sweden 2,253 47.8% 14.2% 36.5% 15.6%
Switzerland 813 46.7% 13.3% 29.7% 13.1%
All 10 countries 16,695 50.7% 16.2% 36.9% 19.1%
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practitioners in men (model 3: obesity class I: OR 1.5, 95%
CI 1.2–2.0; obesity class II–III: OR 1.8, 95% CI 1.1–3.0)
and for polymedication in both men (model 3: obesity
class I: OR 1.3, 95% CI 0.9–1.7; obesity class II–III: OR
1.9, 95% CI 1.1–3.1) and women (model 3: obesity class I:
OR 1.6, 95% CI 1.3–2.1; obesity class II–III: OR 2.2, 95%
CI 1.5–3.2).
With respect to hospitalization, the risk decreased for
overweight men, but rose for obese women. However, this
decreased risk of hospitalization for overweight men was
only marginally significant, and exploring two different
components of men’s hospitalization (times hospitalized,
nights spent in hospital) did not disclose significant
associations. Men and women, whether overweight or obese,
did not report significantly higher use of specialists, surgery,
home healthcare or domestic help. The increased use of
home services observed in obese women was explained by
socio-economic status and behavioral risk factors.
Because the country variable might be considered as an
effect modifier of the association BMI-healthcare utiliza-
tion, we performed country-level analyses. The latter was
performed on pooled data for men and women because the
utilization results did not differ much by gender, and
country sample sizes were reduced. After adjustment for
age, gender, socio-economic status and behavioral risk
factors, results showed similar trends in odds ratios for
ambulatory care visits, general practitioner visits, medica-
tion use, hospitalization and surgery. Utilization of special-
ists varied more across countries, with Austrian, French,
German, Greek, Spanish and Swedish overweight and/or
obese participants tending to report less use of specialists
during the previous 12 months. The latter odds ratios were
not significant, however.
Statistically, none of the associations between BMI and
healthcare utilization varied by age category or country of
residence (test for BMI*age and BMI*country interactions,
P>0.05), and none of the point estimates changed when
considering supplementary insurance as another confound-
ing variable.
The population attributable fractions for high use of
ambulatory care were 3% for overweight and obese men
and 12% for overweight and obese women. PAFs for high
use of general practitioners were 15% and 13% for
overweight and obese men and women, respectively, and
23% for men and 19% for women for high use of
medications. Among women, hospitalization could be
ascribed to overweight and obesity in 12% of the cases.
Discussion
Our results show that in Europe, for both men and women,
being overweight and being obese were similarly associated
with increased use of ambulatory care visits, general
practitioner visits and medication use, but not with visits
to specialists, surgery, home healthcare or domestic help.
As shown using three separate logistic regression models,
these associations did not appear to depend on the
individuals’ age, socio-economic status and behavioral risk
factors. They may rather be related to the most frequently















Ppp-household income adjusted for household size (Euros)
25th percentile 13,308 10,889
50th percentile 23,295 19,620
75th percentile 39,459 34,520
Married or registered partnership, % 79.2 63.6
Currently smoking, % 25.9 14.6
Neither moderate nor vigorous
physical activity, %
7.8 10.6
Drinking ≥2glasses of alcohol
5/6 days a week, %
27.5 7.1
Number of physician’s diagnosed chronic diseases a, %
0 29.8 24.7
1 33.8 32.0
2 or more 36.4 43.2
2 or more health complaints b, %
0 37.9 24.8
1 34.4 31.5
2 or more 27.7 43.6
Fair or poor subjective health (vs. excellent/very
good/good), %
29.7 35.5
Difficulties in any of five activities of daily living
(bathing, dressing, eating, walking across a
room and getting in or out of bed), %
8.5 7.0
a Physicians’ diagnosed chronic conditions (“Has a doctor ever
toldyou that you had any of the conditions on this card?”): high
blood pressure or hypertension; high blood cholesterol; stroke or
cerebrovascular disease; diabetes or high blood sugar; chronic lung
disease such as bronchitis or emphysema; asthma; arthritis,
including osteoarthritis or rheumatism; osteoporosis; cancer or
malignant tumor, including leukemia or lymphoma, but excluding
minor skin cancers; stomach or duodenal ulcer, peptic ulcer;
Parkinson’s disease; cataract; hip fracture or femoral fracture; other
condition, not yet mentioned.
b Health complaints (“For the past 6 months, have you been bothered
by any of the health conditions on this card?”): pain in your back,
knees, hips or any other joint; heart trouble or angina, chest pain
during exercise; breathlessness, difficulty breathing; persistent
cough; swollen legs; sleeping problems; falling down; fear of
falling down; dizziness, faints or blackouts; stomach or intestine
problems, including constipation, air, diarrhea; incontinence or
involuntary loss of urine; other symptom, not yet mentioned.
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described obesity-related chronic conditions-particularly for
obese individuals-and obesity itself. In addition, their
direction was constant across countries and their healthcare
systems, except for the use of specialists.
A large database of men and women from ten European
countries, the use of standardized questionnaires and
procedures, the availability of a data set allowing compre-
hensive adjustments and separate analyses for men and
women were the main strengths of this study. However, a
number of limitations have to be considered. The first was
the fact that height and weight were self-reported. Because
men and women generally overestimate their height and
underestimate their weight, particularly if they are obese,
BMI tends to be underestimated (Connor Gorber et al.
2007; Palta et al. 1982). Therefore, the true percentage of
the overweight and obese population may be higher than
our estimates, and the healthcare utilization adjusted
associations are likely to be overestimated. Secondly, the
overall response rate was modest (62%), particularly due to
a poor participation in Switzerland (37.8%). Despite the
latter, the age, sex, subjective health and BMI character-
istics of the Swiss sample were similar to those of the 2002
Swiss Health Care Survey (unpublished results). Thirdly,
even if social security or statutory health insurance
coverage is almost universal in countries participating in
SHARE, supplementary and private insurances might still
improve access to care. Owing to their complexity, they
cannot be fully adjusted for in analyses. However,
considering the mere fact of reporting any supplementary
insurance did not modify the results. Fourthly, due to the
cross-sectional nature of the analysis, causality cannot be
inferred. Whether overweight and/or obesity appeared
before or after healthcare use cannot be determined. Even
though part of the use that we model could be the effect of
successful healthcare of overweight and obese individuals,
such an inverse causality is very unlikely. Finally, the use of
self-reported data could result in information and recall
biases, and residual or unmeasured confounding cannot be
excluded.
The healthcare systems of the ten countries included in
the SHARE study are diverse. In each country, however,
almost all citizens are covered by some type of health
insurance (Colombo and Tapay 2004). Because the country
of residence is associated both with BMI (the prevalence of
excess weigh differs across countries) and healthcare
utilization (different utilization patterns across countries),
it was considered as a potential confounding variable.
Furthermore, the country of residence may also have acted
Table 3 Health services utilization during the previous 12 months, by BMI category and gender
Normal weight Overweight Obesity P value
Men (n=2,597) (n=3,982) (n=1,275)
At least one ambulatory care visit, % 80.9% 85.5% 85.2% <0.01
Specialist consulted, % 91.3% 92.6% 92.5% 0.75
High use of ambulatory care (≥4 visits), % 43.5% 51.6% 62.8% <0.001
High use of general practitioners (≥4 visits), % 40.1% 47.0% 59.2% <0.001
Polymedication (≥2 medication categories), % 24.7% 32.8% 44.9% <0.001
Hospitalization, % 14.6% 12.1% 14.9% 0.09
Among those hospitalized:
-High use of hospital (≥2 times/past 12 months) 40.8% 29.4% 31.0% 0.08
-High number of nights (overall, ≥7 nights) 57.4% 52.4% 56.4% 0.61
Any surgery, % 12.2% 10.5% 11.0% 0.32
Any home healthcarea, % 3.1% 2.4% 3.6% 0.34
Any domestic helpa, % 1.2% 1.6% 1.4% 0.77
Women (n=3,899) (n=3,258) (n=1,684)
At least one ambulatory care visit, % 89% 91.2% 93.1% <0.01
Specialist consulted, % 95.2% 94.5% 95.2% 0.76
High use of ambulatory care (≥5 visits), % 44.7% 53.8% 60.9% <0.001
High use of general practitioners (≥4 visits), % 45.6% 55.5% 64.5% <0.001
Polymedication (≥2 medication categories), % 31.7% 42.5% 58.4% <0.001
Hospitalization, % 11.2% 13.5% 16.8% <0.001
Among those hospitalized:
-High use of hospitals (≥2 times/past 12 months) 25.3% 24.5% 28.3% 0.74
-High number of nights (overall, ≥7 nights) 45.9% 50.1% 59.1% 0.07
Any surgery, % 12.3% 13.1% 12.0% 0.69
Any home healthcarea, % 3.3% 2.3% 4.8% <0.01
Any domestic helpa, % 2.6% 2.7% 4.5% 0.03
a Greece and Switzerland excluded from that analysis (see Methods section)
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as an effect modifier of the BMI-healthcare utilization
association. Interaction effects were ruled out in the
modeling process and after performing country-specific
analyses, except for the BMI*country of residence interac-
tion for the use of specialist care. However, these country-
level associations, showing decreased odds ratios for
specialist care were not statistically significant and
remained unexplained.
With respect to higher ambulatory care and medication
use, these findings are consistent with previously published
studies and confirm the impact that overweight and obesity
are shown to have on the US healthcare systems, whether
authors stratified their analysis by gender (Leon-Munoz et al.
2005; Andreyeva et al. 2004; Reidpath et al. 2002) or not
(Bertakis and Azari 2005; von Lengerke et al. 2005; Raebel
et al. 2004; Luchsinger et al. 2003; Ostbye et al. 2002;
Quesenberry et al. 1999; Trakas et al. 1999), or considered
women only (Meisinger et al. 2004; Guallar-Castillon et al.
2002). The most likely explanation may be that the treatment
of obesity itself, and not of obesity-related diseases only,
leads to increased healthcare utilization. Another might be
that physicians, aware of the increased risk associated with
higher BMI, propose different healthcare schedules to their
overweight and obese patients. However, it is surprising to
see that men and women showed such a similar ambulatory
care and medication use, if we take into account the fact that
associations between BMI and health complaints or disabil-
ity seem to differ between genders. In fact, overweight/obese
women are more likely to report symptoms and physical
disability than overweight/obese men (Patterson et al. 2004;
Lean et al. 1999).
With regard to hospitalization, which has not been
consistently shown to be related to BMI (Bertakis and
Azari 2005; von Lengerke et al. 2005; Andreyeva et al.
2004; Luchsinger et al. 2003; Guallar-Castillon et al. 2002;
Quesenberry et al. 1999; Trakas et al. 1999), it remains
Table 4 Association between BMI and healthcare utilization (adjusted odds ratios)a
Model 1 Model 2 Model 3
Overweight Obesity Overweight Obesity Overweight Obesity
Men
At least one ambulatory care visit 1.4 (1.2–1.8) 1.4 (1.1–1.9) 1.4 (1.1–1.7) 1.4 (1.0–1.9) 1.2 (1.0–1.5) 0.9 (0.7–1.3)
High use of ambulatory care (≥4 visits) 1.4 (1.2–1.7) 2.4 (1.9–2.9) 1.4 (1.2–1.7) 2.3 (1.8–2.8) 1.2 (1.0–1.4) 1.6 (1.3–2.0)
High use of general practitioners (≥4 visits) 1.4 (1.1–1.6) 2.4 (1.9–3.0) 1.3 (1.1–1.6) 2.2 (1.7–2.7) 1.2 (1.0–1.4) 1.6 (1.2–2.0)
Specialist consulted 1.2 (0.8–2.0) 1.3 (0.7–2.4) 1.2 (0.8–2.0) 1.3 (0.7–2.4) 1.1 (0.7–1.8) 1.1 (0.6–2.1)
Polymedication (≥2 medication categories) 1.6 (1.3–1.9) 2.8 (2.2–3.4) 1.5 (1.3–1.8) 2.6 (2.1–3.3) 1.1 (0.9–1.4) 1.4 (1.0–1.8)
Hospitalization 0.8 (0.6–1.0) 1.0 (0.8–1.4) 0.8 (0.6–1.0) 1.0 (0.7–1.3) 0.7 (0.6–0.9) 0.8 (0.6–1.1)
Among those hospitalized:
-High use of hospital (≥2 times/12 m) 0.6 (0.4–1.0) 0.7 (0.4–1.2) 0.7 (0.4–1.1) 0.7 (0.4–1.3) 0.7 (0.4–1.1) 0.7 (0.4–1.3)
-High overall number of nights (≥7 nights) 0.8 (0.6–1.4) 1.0 (0.6–1.8) 0.9 (0.6–1.4) 1.0 (0.6–1.8) 0.8 (0.5–1.3) 0.9 (0.5–1.7)
Any surgery 0.9 (0.7–1.1) 0.9 (0.7–1.2) 0.8 (0.7–1.0) 0.8 (0.6–1.1) 0.8 (0.6–1.1) 0.8 (0.5–1.0)
Home healthcareb 0.9 (0.5–1.4) 1.3 (0.7–2.6) 0.8 (0.5–1.3) 1.2 (0.7–2.5) 0.8 (0.5–1.3) 1.1 (0.6–2.2)
Domestic helpb 1.5 (0.7–3.2) 1.4 (0.6–3.2) 1.6 (0.8–3.3) 1.3 (0.5–3.1) 1.5 (0.7–3.2) 0.9 (0.4–2.4)
Women
At least one ambulatory care visit 1.3 (1.0–1.7) 1.7 (1.2–2.4) 1.3 (1.0–1.7) 1.6 (1.2–2.3) 1.2 (0.9–1.5) 1.2 (0.8–1.7)
High use of ambulatory care (≥4 visits) 1.4 (1.2–1.6) 1.9 (1.6–2.2) 1.4 (1.2–1.6) 1.7 (1.4–2.1) 1.2 (1.1–1.5) 1.3 (1.1–1.6)
High use of general practitioners (≥4 visits) 1.5 (1.3–1.8) 2.2 (1.8–2.7) 1.5 (1.2–1.7) 1.9 (1.6–2.4) 1.3 (1.1–1.5) 1.5 (1.2–1.8)
Specialist consulted 1.0 (0.6–1.5) 1.2 (0.7–2.0) 1.0 (0.6–1.6) 1.3 (0.8–2.2) 0.9 (0.6–1.5) 1.1 (0.6–1.9)
Polymedication (≥2 medication categories) 1.6 (1.3–1.8) 3.1 (2.6–3.7) 1.5 (1.3–1.8) 2.8 (2.3–3.4) 1.2 (1.0–1.5) 1.8 (1.4–2.2)
Hospitalization 1.2 (1.0–1.5) 1.6 (1.3–2.1) 1.2 (1.0–1.5) 1.4 (1.1–1.8) 1.1 (0.9–1.4) 1.1 (0.8–1.5)
Among those hospitalized:
-High use of hospital (≥2 times/12 m) 0.9 (0.6—1.5) 1.1 (0.7—1.9) 1.0 (0.6—1.6) 1.0 (0.6—1.7) 1.0 (0.6—1.6) 1.1 (0.6–1.9)
-High overall number of nights (≥7 nights) 1.2 (0.7–1.8) 1.9 (1.1–3.0) 1.2 (0.8–2.0) 1.8 (1.1–3.1) 1.2 (0.7–1.9) 1.7 (1.0–2.8)
Any surgery 1.1 (0.9–1.4) 1.0 (0.8–1.3) 1.1 (0.9–1.4) 1.0 (0.7–1.3) 1.1 (0.8–1.3) 0.9 (0.6–1.2)
Home healthcareb 0.9 (0.6–1.3) 1.9 (1.2–3.0) 0.8 (0.5–1.3) 1.4 (0.8–2.3) 0.7 (0.4–1.1) 1.0 (0.5–1.7)
Domestic helpb 1.0 (0.7–1.6) 1.8 (1.1–3.0) 1.1 (0.7–1.8) 1.4 (0.8–2.5) 1.1 (0.6–1.8) 1.2 (0.7–2.3)
In bold Significant ORs (P value<0.05)
a Normal weight is the reference (OR=1)
b Greece and Switzerland excluded from that analysis (see Research Methods and Procedures section)
Model 1: adjusted for age and country
Model 2: adjusted as for model 1 + socio-economic status, smoking, physical activity and alcohol consumption
Model 3: adjusted as for model 2 + cardiovascular diseases, high blood pressure, high cholesterol, diabetes and arthritis
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unclear why overweight men were at decreased risk of, and
obese women at increased risk of hospitalization. While the
latter could be related to the higher incidence of morbidity
among obese individuals, the decreased use of hospitals by
overweight men may parallel the absence of a relationship
between overweight and negative health outcomes among
elderly men that is sometimes described in the literature
(Arterburn et al. 2004). However, we have to be cautious
with the interpretation of the decreased risk of hospitaliza-
tion of overweight men since its significance was only
marginal, and exploration of other dimensions of hospital
stays did not reveal significant odds ratios.
Unexpected is the finding that neither overweight nor
obesity was associated with increased use of home health-
care or domestic help, despite the known relationship that
exists between BMI and physical disability or functional
limitations (Larrieu et al. 2004; Lean et al. 1999). Even
though the situation in men could be partly explained by
wives acting as caregiver in many households, this is
unlikely to be an explanation for the care of overweight/
obese women themselves. More probably, the lack of
significant associations is due to the relatively small
number of disabled men and women having used those
services during the previous 12 months, and also possibly
due to the fact that these services are not always included in
the countries’ basic health insurance package.
Population attributable fractions focus attention on
populations and give another perspective to the results that
depends not only on the magnitude of the association (OR),
but also on the prevalence of the exposure (overweight and
obesity). Its use may be debatable here because the PAF
calculation assumes causality, which cannot be confirmed
with our cross-sectional data. However, an inverse causality
(i.e., high utilization leads to excess weight) is very
unlikely. Although fully adjusted ORs were relatively high
(overall, significant associations showed a 20 to 80%
increased risk of utilization), the total burden for healthcare
systems attributable to overweight and obesity varied
between a low 3% and 23%.
Despite the rising prevalence of obesity and aging of the
population, findings from SHARE show that the burden
overweight and obese individuals place on European
healthcare systems is moderate. In terms of health services,
this will particularly impact ambulatory care and medica-
tions. Future research may help explore the content and
outcomes of ambulatory care visits, as measured by quality
of care indicators, and further investigate how BMI impacts
other healthcare utilization aspects such as nursing and
social health services.
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